Kringle Pharma, Inc. (TYO:4884)
Japan · Delayed Price · Currency is JPY 611.00
+47.00 (8.33%)
Oct 6, 2026, 3:30 PM JST
Kringle Pharma Market Cap
Kringle Pharma has a market cap or net worth of 5.12 billion as of October 6, 2026. Its market cap has increased by 66.85% in one year.
Market Cap
5.12B
Enterprise Value
4.05B
Revenue
342.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
611.00
ChartMarket Cap Chart
Since December 28, 2020, Kringle Pharma's market cap has increased from 5.09B to 5.12B, an increase of 0.71%. That is a compound annual growth rate of 0.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 5.12B | 81.32% |
| Dec 30, 2025 | 2.82B | -52.49% |
| Dec 30, 2024 | 5.95B | 30.66% |
| Dec 29, 2023 | 4.55B | 47.85% |
| Dec 30, 2022 | 3.08B | -0.04% |
| Dec 30, 2021 | 3.08B | -45.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TMS Co., Ltd. | 5.75B |
| Soiken Holdings | 5.62B |
| PRISM BioLab Co.,LTD | 5.40B |
| Noile-Immune Biotech | 5.08B |
| Chordia Therapeutics | 4.79B |
| Ribomic | 4.30B |
| D. Western Therapeutics Institute | 4.26B |
| Kohjin Bio | 4.21B |